Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Comparative evaluation of pharmaceutical products obtained in Mexico: augmenting existing scientific data.

Authors
Type
Published Article
Journal
Drug Development and Industrial Pharmacy
1520-5762
Publisher
Informa UK (Taylor & Francis)
Publication Date
Volume
38
Issue
7
Pages
808–814
Identifiers
DOI: 10.3109/03639045.2011.628678
PMID: 22091930
Source
Medline
License
Unknown

Abstract

All of the samples analyzed for the two ciprofloxacin products and the two ampicillin products were found to be within the USP limits. Of the four different sulfamethoxazole/trimethoprim products tested, all were within USP limits for sulfamethoxazole, but contained 2-3 individual units which were outside of USP limits for trimethoprim. Several of the remaining products (amoxicillin, levothyroxine, sildenafil citrate, and warfarin) had individual units that fell outside of the USP limits, although only one of the levothyroxine products (1 out of 20 tablets tested) and both sildenafil citrate products (all of the units tested) contained units outside of ±25% label claim.

Statistics

Seen <100 times